X4 Pharmaceuticals, Inc. (XFOR)
4.24
-0.11
(-2.53%)
USD |
NASDAQ |
Apr 02, 16:00
4.23
-0.01
(-0.24%)
After-Hours: 20:00
X4 Pharmaceuticals EPS Diluted (Quarterly) : -0.2164 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Immuneering Corp. | -0.1793 |
| Tango Therapeutics, Inc. | -0.2945 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.92M |
| Revenue (Quarterly) | 2.568M |
| Total Expenses (Quarterly) | 26.49M |
| Enterprise Value | 208.98M |
| Gross Profit Margin (Quarterly) | 84.93% |
| Profit Margin (Quarterly) | -931.7% |
| Earnings Yield | -105.2% |
| Normalized Earnings Yield | -137.73 |